NCT04532203View on ClinicalTrials.gov

A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2026

Conditions
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
Interventions
DRUG

CAR-T cells

Each subject receive CAR T-cells by intravenous infusion

PROCEDURE

Ommaya Reservoir

Surgical catheter placement into the fourth ventricle of the brain

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Zhejiang University

OTHER